Comparative Efficacy of Topical N-Acetylcysteine-Doxycycline versus Benzoyl Peroxide-Doxycycline in Moderate Acne Vulgaris: Add-on Double-Blind Randomized Controlled Trial
Dermatology Practical & Conceptual · 30.04.2026 · 16 (2) · 6215
DOI: 10.5826/dpc.1602a6215 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 30.04.2026. Verfasst von Mohammad Mahdi Parvizi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Dermatology Research Center, Shiraz, Iran. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Acne vulgaris is a prevalent skin disorder affecting approximately 85% of adolescents. While topical retinoid and benzoyl peroxide (BPO) are standard treatments, their side effects often decrease patient adherence.
Objectives
Due to the potential side effects of these drugs, we decided to explore the efficacy and safety of topical N-acetylcysteine (NAC) plus doxycycline compared to BPO-doxycycline in moderate acne vulgaris.
Method
In this double-blind, randomized clinical trial, 40 patients were divided into two groups: Group A received 100 mg/day doxycycline+5% NAC, while Group B received 100 mg/day doxycycline +5% BPO. Patients were assessed over three months using Total Lesion Count (TLC), Investigator Global Assessment (IGA), Global Acne Grading System (GAGS), and Cardiff Acne Disability Index (CADI). Statistical analysis was performed using STATA 14.2, with p < 0.05 considered significant.
Results
The NAC group showed a significantly greater reduction in CADI scores (MD=-3.60, 95% CI: -4.26 to -2.95, p < 0.001), GAGS scores (MD = -9.76, 95% CI: -11.84 to -7.68, p < 0.001), and TLC (MD = -4.29, 95% CI: -6.38 to -2.19, p = 0.002) compared to BPO. IGA scores also improved more significantly in the NAC group (MD = -0.85, 95% CI: -1.12 to -0.58, p < 0.001). Only one patient reported mild scaling with NAC, suggesting better tolerability.
Conclusion
Topical NAC combined with doxycycline was significantly more effective than BPO-doxycycline in reducing acne severity and lesion count, with minimal adverse effects. NAC may serve as a more efficacious alternative for treating moderate acne vulgaris.
Autor:innen und Institutionen
- Molecular Dermatology Research Center, Shiraz, Iran.
- Research Center for Traditional Medicine and History of Medical Science, Tehran, Iran.
- Vice Chancellor of Academic Affairs, Smart University of Medical Sciences, Tehran, Iran.
- Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Quality Control, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Zitieren
APA
Parvizi, M. M., Mosallanezhad, P., Hekmat, M., Alipour, S., & Haghighi, N. F. (2026). Comparative Efficacy of Topical N-Acetylcysteine-Doxycycline versus Benzoyl Peroxide-Doxycycline in Moderate Acne Vulgaris: Add-on Double-Blind Randomized Controlled Trial. Dermatology Practical & Conceptual, 16(2), 6215. https://doi.org/10.5826/dpc.1602a6215
Vancouver
Parvizi MM, Mosallanezhad P, Hekmat M, Alipour S, Haghighi NF. Comparative Efficacy of Topical N-Acetylcysteine-Doxycycline versus Benzoyl Peroxide-Doxycycline in Moderate Acne Vulgaris: Add-on Double-Blind Randomized Controlled Trial. Dermatology Practical & Conceptual. 2026;16(2):6215. doi:10.5826/dpc.1602a6215
BibTeX
@article{Parvizi2026,
author = {Parvizi, Mohammad Mahdi and Mosallanezhad, Parisa and Hekmat, Maryam and Alipour, Shohreh and Haghighi, Negin Fazelzadeh},
title = {Comparative Efficacy of Topical N-Acetylcysteine-Doxycycline versus Benzoyl Peroxide-Doxycycline in Moderate Acne Vulgaris: Add-on Double-Blind Randomized Controlled Trial},
journal = {Dermatology Practical & Conceptual},
year = {2026},
volume = {16},
number = {2},
pages = {6215},
doi = {10.5826/dpc.1602a6215}
}
EUVIMED